As 2025 unfolds, the world of mass tort litigation shows no signs of slowing down. From pharmaceutical giants to tech behemoths, corporations across industries are facing an unprecedented wave of lawsuits that could reshape their futures. With judges issuing critical rulings, multidistrict litigation (MDL) panels consolidating cases, and bellwether trials on the horizon, the legal …
Per- and polyfluoroalkyl substances (PFAS), often referred to as “forever chemicals,” have become a focal point of environmental and public health concerns in the United States. These synthetic chemicals, used for their water, heat, and grease-resistant properties, are now at the center of one of the largest mass tort litigations in U.S. history. With thousands …
Ultra-processed foods (UPFs) have become a cornerstone of modern diets, but their convenience comes at a cost. As consumption of these foods has skyrocketed, so too have the alarming health complications linked to them, including obesity, diabetes, heart disease, and even certain cancers. This growing public health crisis has sparked a wave of litigation against …
The Ultra-Processed Foods Lawsuit: A Must-Know Update for Mass Tort Lawyers Read More »
What is BioZorb? The BioZorb litigation is shaping up to be one of the most significant legal challenges of 2025, presenting a unique opportunity for plaintiff attorneys nationwide. This case revolves around a medical device designed to aid breast cancer patients but has since been linked to serious complications, sparking widespread litigation. As the legal …
Understanding the BioZorb Litigation: A Growing Legal Battle for Plaintiff Attorneys Read More »
The legal landscape surrounding Depo-Provera litigation is complex and still evolving, but understanding key trends and challenges can help legal professionals navigate this landscape with greater confidence. Depo-Provera, a contraceptive injection that has been on the market for decades, is now at the center of mounting lawsuits linking its use to an increased risk of …
Depo-Provera: Insights for Lawyers in the Evolving Litigation Landscape Read More »
A Growing Need for High-Quality Roundup Claimants As Roundup litigation continues to unfold, the volume of claims related to its potential link to Non-Hodgkin’s Lymphoma (NHL) continues to grow. This has led to an increasing demand for claimant leads that are not only legitimate but also meet specific criteria set by law firms. The challenge, …
Oxbryta Litigation: A Deep Dive into the Legal Challenges and Industry Implications. The recent recall of Oxbryta (voxelotor), a medication designed to treat sickle cell disease (SCD), has led to a wave of legal challenges that are reverberating throughout the pharmaceutical industry. Initially heralded as a breakthrough treatment for SCD, Oxbryta was approved by …
